Glenn Dranoff
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 82
- Immunotherapy and Immune Responses 68
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 3
- Oncology 54
- Cancer Immunotherapy and Biomarkers 38
- CAR-T cell therapy research 7
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Ira Mellman (1 shared paper)George Coukos (1 shared paper)Matthew W. Vanneman (9 shared papers)Richard C. Mulligan (21 shared papers)Michael Lawrence Dougan (12 shared papers)Frank Stephen Hodi (26 shared papers)David J. Mooney (9 shared papers)Gordon James Freeman (9 shared papers)
- Journals
- Cancer Immunology Research (20 papers)Blood (17 papers)Proceedings of the National Academy of Sciences (14 papers)Clinical Cancer Research (13 papers)The Journal of Experimental Medicine (7 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Glenn Dranoff
235 papers receiving 39.9k citations
Glenn Dranoff's Hit Papers
Peers
Comparison fields: 5 of 121
- Immunology 9.4k
- Oncology 8.8k
- Genetics 1.9k
- Cancer Research 756
- Hematology 880
Countries citing papers authored by Glenn Dranoff
This map shows the geographic impact of Glenn Dranoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Dranoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Dranoff more than expected).
Fields of papers citing papers by Glenn Dranoff
This network shows the impact of papers produced by Glenn Dranoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Dranoff. The network helps show where Glenn Dranoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Glenn Dranoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer immunotherapy comes of age Hit paper breakdown → | 2011 | 3345 |
| 2 | Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Hit paper breakdown → | 1993 | 2406 |
| 3 | Combining immunotherapy and targeted therapies in cancer treatment Hit paper breakdown → | 2012 | 1336 |
| 4 | Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints Hit paper breakdown → | 2016 | 1324 |
| 5 | Cytokines in cancer pathogenesis and cancer therapy Hit paper breakdown → | 2004 | 1244 |
| 6 | Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors Hit paper breakdown → | 2013 | 1084 |
| 7 | Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis Hit paper breakdown → | 2015 | 880 |
| 8 | 2007 | 862 | |
| 9 | Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Hit paper breakdown → | 2003 | 850 |
| 10 | Prospects for combining targeted and conventional cancer therapy with immunotherapy Hit paper breakdown → | 2017 | 827 |
| 11 | Coinhibitory Pathways in Immunotherapy for Cancer Hit paper breakdown → | 2016 | 767 |
| 12 | Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis Hit paper breakdown → | 1994 | 751 |
| 13 | 1997 | 751 | |
| 14 | 2015 | 580 | |
| 15 | 2007 | 552 | |
| 16 | 2008 | 540 | |
| 17 | Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors Hit paper breakdown → | 2018 | 523 |
| 18 | 2008 | 519 | |
| 19 | 2016 | 519 | |
| 20 | 2006 | 516 |
About Glenn Dranoff
Glenn Dranoff is a scholar working on Immunology, Oncology, Hematology, Genetics and Genetics, having authored 240 papers that have together received 41.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (68 papers), Cancer Immunotherapy and Biomarkers (38 papers), Virus-based gene therapy research (8 papers), T-cell and B-cell Immunology (7 papers), CAR-T cell therapy research (7 papers), Glioma Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (9.4k citations), Oncology (8.8k citations), Genetics (1.9k citations), Cancer Research (756 citations) and Hematology (880 citations). Glenn Dranoff has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Ira Mellman, George Coukos, Matthew W. Vanneman, Richard C. Mulligan, Michael Lawrence Dougan, Frank Stephen Hodi, David J. Mooney, Gordon James Freeman, Elizabeth M. Jaffee and Drew M. Pardoll. Their work appears in journals such as Cancer Immunology Research, Blood, Proceedings of the National Academy of Sciences, Clinical Cancer Research and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.